New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
08:15 EDTABBVAbbVie price target raised to $65 from $59 at Argus
Argus increased its price target on AbbVie after the company raised its 2014 EPS guidance. The firm is upbeat on the company's new products and keeps a Buy rating on the shares.
News For ABBV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
09:07 EDTABBVFDA making testosterone product makers change labeling
Subscribe for More Information
07:10 EDTABBVCowen to hold a conference
35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 4 at 8 am; not all company presentations may be webcasted. Webcast Link
March 3, 2015
11:46 EDTABBVLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
February 23, 2015
11:19 EDTABBVEnanta announces JAMA publication of AbbVie VIEKIRA PAK study results
Subscribe for More Information
11:04 EDTABBVAbbVie reports VIEKIRA PAK HPV/HIV co-infection study results published
Subscribe for More Information
February 20, 2015
10:33 EDTABBVBattleground update: AbbVie named top global pick at Jefferies
Subscribe for More Information
07:23 EDTABBVAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
February 19, 2015
12:13 EDTABBVAbbVie increases quarterly dividend 4% to 51c per share
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use